Hospital Santi Paolo e Carlo - ASST Milan

Italy

asst_santi_paolo_e_carlo_picture.jpg

Contact Information for physicians/patients

piermaria.battezzati(at)unimi.it
stefania.casu(at)asst-santipaolocarlo.it
andrea.crosignani(at)asst-santipaolocarlo.it
val.corvaglia(at)gmail.com

Particular rare liver disease expertise of the centre

  • Primary Biliary Cholangitis (PBC)
  • Autoimmune Hepatitis (AIH)
  • Primary Sclerosing Cholangitis (PSC)
  • Wilsons Disease
  • Hemochromatosis

ERN Representatives

  • portrait-placeholder.png

    Prof. Pier Maria Battezzati, MD

  • portrait-placeholder.png

    Andrea Luigi Crosignani, MD


ERN Team and Contact

Prof. Pier Maria Battezzati, MD. Gastroenterology and Liver Unit, Head

Andrea Crosignani, MD. Gastroenterology and Liver Unit at the San Paolo hospital

Stefania casu, MD. Gastroenterology and Liver Unit at the San Carlo Borromeo hospital

Valerio Corvaglia, PhD, Clinical study coordinator


Centre information

Gastroenterology and Liver Unit, ASST Santi Paolo e Carlo, Milan

ASST Santi Paolo e Carlo is a public health centre based upon two university hospitals: San Paolo (480 beds) and San Carlo Borromeo hospital (560 beds), both located in the South-Western area of Milan. Overall, the two hospitals serve a population of about 400,000 inhabitants. Clinical, teaching and research activities of the Gastroenterology and Liver Unit extend over both hospitals, with a specific interest to patients with chronic liver diseases. It operates as a tertiary referral centre for patients with autoimmune hepatitis, chronic cholestatic diseases of autoimmune origin, and Wilson’s disease. Patient care is oriented towards a multidisciplinary approach, with strong commitment to integrate the team’s expertise in the hepatology, gastrointestinal and internal medicine fields with the in-house network of specialists expert in endoscopy, diagnostic/interventional radiology, liver surgery, intensive-care, haematology and neurology. The Unit works in close cooperation with the liver transplant centres at the Niguarda hospital and the Istituto Nazionale Tumori in Milan.